ASH

Ashland Global Holdings Inc

ASH, USA

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.

https://www.ashland.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

Quarterly

Rate:

0.415

Next Payout:

Dec 15, 2025

Yield:

2.7741 %
ASH
stock
ASH

Evaxion Biotech stock holds Buy rating at H.C. Wainwright after ASH data Investing.com Canada

Read more →
ASH
stock
ASH

Evaxion Biotech stock holds Buy rating at H.C. Wainwright after ASH data Investing.com UK

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$63.2

Analyst Picks

Strong Buy

6

Buy

1

Hold

4

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Low

1.46

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

1.69 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.69 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

17.99 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.45

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 70.86% of the total shares of Ashland Global Holdings Inc

1.

Vanguard Group Inc

(10.1763%)

since

2025/06/30

2.

BlackRock Inc

(9.8575%)

since

2025/03/31

3.

AQR Capital Management LLC

(7.5584%)

since

2025/06/30

4.

Massachusetts Financial Services Company

(6.2297%)

since

2025/06/30

5.

Dimensional Fund Advisors, Inc.

(5.4986%)

since

2025/06/30

7.

Cooperman Leon G

(3.7194%)

since

2025/06/30

8.

State Street Corp

(3.3872%)

since

2025/03/31

9.

Diamond Hill Capital Management Inc

(3.2753%)

since

2025/06/30

10.

1832 Asset Management L.P

(3.0013%)

since

2025/06/30

11.

Shapiro Capital Management Co Inc

(1.8654%)

since

2025/06/30

12.

Geode Capital Management, LLC

(1.7951%)

since

2025/03/31

13.

Charles Schwab Investment Management Inc

(1.3217%)

since

2025/06/30

14.

Qube Research & Technologies

(1.2584%)

since

2025/06/30

15.

D. E. Shaw & Co LP

(1.2518%)

since

2025/06/30

16.

Macquarie Group Ltd

(1.1812%)

since

2025/03/31

17.

Newport Trust Co.

(1.1708%)

since

2025/06/30

18.

Northern Trust Corp

(1.1423%)

since

2025/03/31

19.

Morgan Stanley - Brokerage Accounts

(1.0908%)

since

2025/03/31

20.

Bank of America Corp

(1.0697%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(7)
Defensive
Highly Defensive(7.5)
Dividend
Decent Dividend Payer(4)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(5)
Value
Undervalued(6.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.